Skip to main content

Our projects

Providing better support for people during a pandemic

The “Collaborative Outcomes Study on Health and Functioning during Infection Times” (COH-FIT), which involves almost 200 researchers from over 40 countries on six continents, aims to measure the impact of the COVID-19 on physical and mental health.

Read more

Predicting the severity of the illness using immune signatures

The research project “Defining the immune signatures in SARS-CoV-2 infected individuals in blood and tissues” aims to identity the biological markers that predict the severity of the illness.

Read more

Host determinants of severe COVID-19, learning from extreme cases

Supported by the SNF, this research project is based on the hypotheses that severe presentation of COVID-19 results from genetic predisposition and that transcriptomic profiling at an early stage may help predict adverse outcomes.

Read more

Identifying antibodies that can neutralise the coronavirus

As part of the “Corona Accelerated R&D in Europe” (CARE) programme, the Allergy and Immunology Department at CHUV has secured funding of almost 5 million Swiss francs for its work aimed at isolating antibodies that neutralise the coronavirus.

Read more

Coordinating the Swiss arm of “Solidarity”

Supported by the Swiss National Science Foundation (NSF) and in collaboration with the Federal Office of Public Health (FOPH), CHUV is coordinating Switzerland’s participation in the “Solidarity” study.

Read more

Developing the leading blood test for Switzerland

In conjunction with the École polytechnique fédérale de Lausanne (EPFL) and the Swiss Vaccine Research Institute (SVRI), CHUV has developed the blood test selected for conducting population studies in Switzerland.

Read more

Understanding the impact of COVID-19 on pregnancy

CHUV has created the “International COVID-19 and Pregnancy Registry” (COVI-Preg), which aims to assess the impact of SARS-CoV 2 on pregnancy and the health of mothers and newborns.

Read more

Tackling cancer treatment resistance with FLASH

FLASH radiotherapy is a new form of treatment pioneered by the CHUV Service of radiation oncology.

Read more

Walking again

High hopes are being raised by the STIMO project, which has enabled some paralysed persons to regain the use of their legs.

Read more

Adapting hospitals for our seniors

CHUV aims to turn itself into a more elderly-friendly hospital by 2023. Measures are planned to adapt the pace and type of care.

Read more

Healing severe burn victims

A pioneer in biological bandages for burn victims, CHUV now hopes to give them antimicrobial properties.

Read more

Uncovering the mysteries of lymph

Unique in Switzerland, CHUV’s lymphatic vessel imaging technique is improving treatments for lymphoedema.

Read more

Giving birth in a more natural position

Imaging, biomechanics and obstetrics professionals are joining forces to find the best positions for vaginal delivery.

Read more

Revealing the cause of death

Forensic imaging has taken a leap forward thanks to the post-mortem angiography technique developed at CHUV. Fluids flow through blood vessels without a beating heart.

Read more

Immunotherapy for children

To fight lymphoblastic leukaemia in children and young adults, the UNIL CHUV Oncology Department and our paediatric oncology consultation have developed an innovative immunotherapy in collaboration with Seattle Children's Hospital.

Read more

A close look at the Lausanne inhabitants

The CoLaus|PsyCoLaus study includes more than 6,700 inhabitants of the city of Lausanne in Switzerland followed for over 15 years. The results of the study have already given rise to more than 470 publications.

Read more

Redefining a night's sleep

Since 2009, HypnoLaus has collected more than 2,000 samples of sleep data from non-selected participants aged 40 to 80.

Read more